COLORECTAL CANCER ALLIANCE
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$16,350,846
Receivables (Non-Related)
38%
Investments
31%
Cash & Equivalents
26%
Other Assets
3%
Property, Plant, & Equipment (net)
2%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$2,159,490
Payables & Accruals
82%
Other Liabilities
18%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$4,051,840
$4,281,042
+6%
Receivables (Non-Related)
$5,460,983
$6,144,093
+13%
Related-Party Receivables
$0
-
-
Inventories
$0
-
-
Prepaid Expenses
$105,408
$103,152
-2%
Investments
$4,800,660
$5,076,588
+6%
Property, Plant, & Equipment (net)
$343,904
$272,751
-21%
Other Assets
$2,048,989
$473,220
-77%
Total Assets
$16,811,784
$16,350,846
-3%
Liabilities
2023
2024
Change
Payables & Accruals
$1,635,733
$1,770,812
+8%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$4,008,965
$388,678
-90%
Total Liabilities
$5,644,698
$2,159,490
-62%
Net assets
2023
2024
Change
Restricted Net Assets
$8,885,434
$10,726,914
+21%
Unrestricted Net Assets
$2,281,652
$3,464,442
+52%
Net assets
2023
2024
Change
Net assets
+$11,167,086
+$14,191,356
+27%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)